Related Experiment Videos
Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras
R Tremain1, M Marko, V Kinnimulki
1Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892, USA.
Abstract:
Previous studies have shown that TGFbeta1 expression is upregulated in mouse keratinocytes infected with a v-rasHa retrovirus, although the functional significance of this has not been clear. Here we show that v-rasHa retrovirus transduced primary mouse keratinocytes undergo hyperproliferation followed by a TGFbeta1 dependent G1 growth arrest and senescence. The growth arrest is accompanied by a 15-fold increase in total TGFbeta1 secreted and a fourfold increase in secreted active TGFbeta1. When cultured in the presence of a neutralizing antibody to TGFbeta1, the senescence response is suppressed. Levels of the TGFbeta1 target p15ink4b increase during senescence as does association of this kinase inhibitor with cyclinD/cdk4 complexes. However, p16ink4a, p53 and p19ARF expression also increase during senescence. Genetic analysis shows that TGFbeta1 null and dominant negative TbetaBRII expressing v-rasHa keratinocytes resist the G1 growth arrest and do not senescence. This resistance is associated with low expression of p15ink4b and p16ink4a, constitutive Rb phosphorylation and high levels of cdk4 and cdk2 kinase activity. In contrast, inactivation of TGFbetabeta1 secretion or response does not block the induction of p53 and p19ARF, but the level of p21waf1, a p53 target gene, is reduced in cyclin D/cdk4 and cyclin E/cdk2 complexes. Thus, although multiple senescence pathways are activated in response to a ras oncogene, inactivation of TGFbeta1 secretion or response is sufficient to block the senescence program. Since v-rasHa transduced TGFbeta1-/- keratinocytes form squamous cell carcinomas following skin grafting, these results suggest that in mouse keratinocytes, defects in TGFbeta1 signaling accelerate malignant progression by overcoming oncogene induced replicative senescence.
Insights
Transforming growth factor beta 1 (TGFbeta1) signaling is crucial for preventing oncogene-induced senescence in mouse keratinocytes. Blocking TGFbeta1 accelerates skin cancer progression by overriding this protective mechanism.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- Upregulation of TGFbeta1 in v-rasHa retrovirus-infected mouse keratinocytes was previously observed but its role was unclear.
- Ras oncogenes can induce cellular senescence, a protective mechanism against cancer development.
Purpose of the Study:
- To elucidate the functional significance of TGFbeta1 upregulation in v-rasHa retrovirus-transduced keratinocytes.
- To investigate the role of TGFbeta1 in oncogene-induced senescence and its impact on malignant progression.
Main Methods:
- Utilized v-rasHa retrovirus transduction in primary mouse keratinocytes.
- Employed neutralizing antibodies against TGFbeta1 to assess its role in senescence.
- Conducted genetic analysis using TGFbeta1 null and dominant-negative TbetaBRII expressing keratinocytes.
- Assessed cell cycle regulators (p15ink4b, p16ink4a, p53, p19ARF, p21waf1) and kinase activity (cdk4, cdk2).
Main Results:
- v-rasHa transduced keratinocytes exhibited hyperproliferation followed by TGFbeta1-dependent G1 growth arrest and senescence.
- Blocking TGFbeta1 with antibodies suppressed senescence and reduced secreted active TGFbeta1 levels.
- TGFbeta1 null or dominant-negative TbetaBRII keratinocytes resisted growth arrest and senescence, showing constitutive Rb phosphorylation and high CDK activity.
- Inactivation of TGFbeta1 signaling did not block p53 and p19ARF induction but reduced p21waf1 levels in cyclin complexes.
Conclusions:
- TGFbeta1 signaling is essential for mediating oncogene-induced G1 growth arrest and senescence in mouse keratinocytes.
- Defects in TGFbeta1 signaling accelerate malignant progression by overcoming ras oncogene-induced replicative senescence.
- TGFbeta1 acts as a critical tumor suppressor by enforcing senescence in response to oncogenic stress.